A preventive approach to oral self-mutilation in Lesch-Nyhan syndrome: A case report

Pediatric Dentistry

Volumn 28, Issue 4, 2006, Pages 341-344

  Jeong, Tae Sung ^a   Lee, Ji Hyun ^a   Kim, Shin ^a   Kim, Ji Hoon ^b   Tootla, Ruwaida G H ^c  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Lesch Nyhan syndrome; Mouthguard; Self mutilation

Indexed keywords

RISPERIDONE; SEROTONIN RECEPTOR AFFECTING AGENT; SERTRALINE;

ARTICLE; AUTOMUTILATION; CASE REPORT; HUMAN; INJURY; LESCH NYHAN SYNDROME; LIP; MALE; MOUTH PROTECTOR; PRESCHOOL CHILD;

CHILD, PRESCHOOL; HUMANS; LESCH-NYHAN SYNDROME; LIP; MALE; MOUTH PROTECTORS; RISPERIDONE; SELF MUTILATION; SEROTONIN AGENTS; SERTRALINE;

EID: 33748569843     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964;36:561-570.
2. Jenkins EA, Hallet RA, Hall RG. Lesch-Nyhan syndrome presenting with renal insufficiency in infancy and transient neonatal hypothyroidism. Br J Rheumatol 1994;5:392-396.
3. Chen LR, Liu JF. Successful treatment of self-inflicted oral mutilation using an acrylic splint retained by a headgear. Pediatr Dent 1996;18:408-410.
4. Nyhan WL, Wong DF. New approaches to understanding Lesch-Nyhan disease. N Eng J Med 1996;334:1602-1604.
5. Sugahara T, Mishima K, Mori Y. Lesch-Nyhan Syndrome: Successful prevention of lower lip ulceration caused by self-mutilation by use of a mouthguard. Int J Oral Maxillofac Surg 1994;23:37-38.
6. Dicks JL, Lesch-Nyhan syndrome: A treatment planning dilemma. Pediatr Dent 1982;4:127-130.
7. Lee JH, Beerkowiz RJ, Choi BJ. Oral self-mutilation in the Lesch-Nyhan syndrome. J Dent Child 2002;69:66-69.
8. Anderson LT, Hermann L, Dancis J. The effect of L-5-hydroxytriptophan on self-mutilation in Lesch-Nyhan disease: A negative report. Neuropadiatrie 1976;7:439-443.
9. Van Moffaert M. Management of self mutilation. Confrontation and integration of psychotherapy and psychotropic drug treatment. Psychother Psychosom 1989;51:180-186.
10. Saemundsson SR, Roberts MW. Oral self-injurious behavior in the developmentally disabled: Review and a case. J Dent Child 1997;64:205-209.
11. Fardi K, Topouuzelis N, Kotsanos N. Lesch-Nyhan Syndrome: A preventive approach to self-mutilation. Int J Paediatr Dent 2003;13:51-56.
12. Breese GR, McCown TJ, Baumeister AA, Emeric SG, Frye GD, Mueller RA. L-DOPA induced self-biting in rats treated with 6-hydroxydopamine(6-OHDA) as neonate: Models of self-mutilation observed in Lesch-Nyhan syndrome. Fed Proc 1984;43:928.
13. King BH, Cromwell HC, Hoa TL, et al. Dopaminergic and glutamatergic interaction in the expression of self-injurious behavior. Dev Neurosci 1998;20:180-187.
14. Plech A, Brus R, Kalbflesch JH, Kostrazewa RM. Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal Mianserin in neonatal 6-OHDA lesioned rats. Psychopharmacology 1995;119:466-473.
15. Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K, Yokogawa K. In vivo dopamine-D2 and serotonine-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacol Biochem Behav 1994;47:553-557.